Role of NLRP3 signals in ischemia/reperfusion-induced organ injury
NLRP3信号在缺血/再灌注引起的器官损伤中的作用
基本信息
- 批准号:10555070
- 负责人:
- 金额:$ 92.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-24 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:2019-nCoVAcuteAcute DiseaseAcute Renal Failure with Renal Papillary NecrosisAddressAffectAnimal ModelAreaBiochemicalBiologicalCOVID-19COVID-19 patientCOVID-19 survivorsCellsChronicChronic Kidney FailureClinicalComplementDataDevelopmentDiseaseDisease ProgressionDoseEpithelialEpithelial CellsEventExhibitsFibrosisGene ExpressionGene Expression ProfileGenesGoalsHealthHistologicHumanIL18 geneImmuneImmune responseImmune signalingImmunologic ReceptorsIn VitroInfectionInflammasomeInflammation MediatorsInflammatoryInjuryInjury to KidneyIschemiaK-18 conjugateKidneyKnowledgeLaboratoriesLearningLinkLong COVIDLungMediatingMiddle East Respiratory Syndrome CoronavirusMolecularMorbidity - disease rateMouse StrainsMultiprotein ComplexesMusNatural ImmunityOrganOrganoidsOutcomePathogenesisPathologicPathway interactionsPatientsPersonsPharmacologyPlayPost-Acute Sequelae of SARS-CoV-2 InfectionPrevention therapyPrimary InfectionProteinsRegulationRenal tubule structureReperfusion TherapyReportingResearchResearch DesignResearch MethodologyRoleSARS coronavirusSARS-CoV-2 infectionSeveritiesSignal PathwaySignal TransductionStudy modelsSurvivorsSymptomsSystemTestingTimeTissuesTubular formationUnited StatesViralVirus Replicationcell typecohortcoronavirus diseaseexperiencehigh riskhuman modelin vivoinduced pluripotent stem cellinhibitorinnate immune pathwaysinsightkidney biopsykidney fibrosiskidney infectionlong term consequences of COVID-19marenostrinmortalitymouse modelnovel therapeuticsorgan injurypost SARS-CoV-2 infectionpreventprogramsresponsesensorsevere COVID-19targeted agenttargeted treatmenttranscriptome sequencing
项目摘要
Project Summary: This proposal evaluates how the cytoplasmic innate immune receptor, NOD-, LRR- and pyrin
domain-containing protein 3 (NLRP3) contributes to chronic kidney disease (CKD) after SARS-CoV2 infection of
human and murine kidneys. The project is highly significant for understanding the steps leading to chronic renal
injury associated with COVID-19 disease.
Broad/long-term objectives: The long-term goals of the proposed research are to define how activation of NLRP3
contributes to chronic injurious tissue responses in human kidneys following SARS-CoV2 infection.
Specific Aims: The central goal of this proposal is to test the hypothesis that SARS-CoV2 infection triggers cell-
type specific responses that affect the NLRP3 pathway, and that dysregulation of this pathway contributes to the
pathogenesis of CKD as a post-acute sequalae of COVID-19 disease.
Research Design and Methods for Achieving the Stated Goals: Aim 1 will examine the effect of SARS-CoV2
infection on NLRP3 pathway activation and its functional consequences in human and murine renal tubular epithelia
and will test consequences of blockade. Aim 2 will examine how SARS-CoV2 infection induces chronic kidney
injury using two murine models of infection, and tests whether blockade of NLRP3 signaling pathways prevents that
injury. Aim 3 will examine the consequences of NLRP3 pathway activation and blockade in SARS-CoV2 chronically
infected human kidney organoids.
Health Relatedness of Project: If the aims of this proposal are met we will learn how activation of NLRP3
contributes to the pathogenesis of the post-acute sequalae of CKD after COVID-19 disease. This knowledge is
crucial for the development of rational target therapies for prevention or amelioration of organ injury following SARS-
CoV2 infection.
项目摘要:该提案评估了细胞质先天免疫受体,点头,LRR-和pyrin如何
SARS-COV2感染后,含域的蛋白3(NLRP3)有助于慢性肾脏疾病(CKD)
人和鼠肾。该项目对于理解导致慢性肾脏的步骤非常重要
与Covid-19疾病有关的损伤。
广泛/长期目标:拟议研究的长期目标是定义NLRP3的激活方式
SARS-COV2感染后,有助于人肾脏的慢性造成伤害组织反应。
具体目的:该提案的核心目标是检验以下假设:SARS-COV2感染触发细胞 -
影响NLRP3途径的特定响应,该途径的失调有助于
CKD作为Covid-19疾病的急性后序列的发病机理。
实现既定目标的研究设计和方法:AIM 1将检查SARS-COV2的效果
NLRP3途径激活的感染及其在人和鼠肾小管上皮中的功能后果
并将测试封锁的后果。 AIM 2将检查SARS-COV2感染如何诱导慢性肾脏
使用两种鼠类感染模型的伤害,并测试NLRP3信号通路的封锁是否阻止
受伤。 AIM 3将检查NLRP3途径激活和封锁SARS-COV2的后果。
被感染的人类肾脏器官。
项目的健康相关性:如果满足该提案的目的,我们将学习如何激活NLRP3
有助于CKD疾病后CKD急性后序列的发病机理。这些知识是
对于预防或改善器官损伤后的理性目标疗法的发展至关重要
COV2感染。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dianne B Mckay其他文献
Dianne B Mckay的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dianne B Mckay', 18)}}的其他基金
Role of NLRP3 signals in ischemia/reperfusion-induced organ injury
NLRP3信号在缺血/再灌注引起的器官损伤中的作用
- 批准号:
10844207 - 财政年份:2021
- 资助金额:
$ 92.44万 - 项目类别:
Role of NLRP3 signals in ischemia/reperfusion-induced organ injury
NLRP3信号在缺血/再灌注引起的器官损伤中的作用
- 批准号:
10659033 - 财政年份:2021
- 资助金额:
$ 92.44万 - 项目类别:
JAML-CAR regulation of adipose tissue homeostasis
JAML-CAR对脂肪组织稳态的调节
- 批准号:
10348218 - 财政年份:2021
- 资助金额:
$ 92.44万 - 项目类别:
JAML-CAR regulation of adipose tissue homeostasis
JAML-CAR对脂肪组织稳态的调节
- 批准号:
10217488 - 财政年份:2021
- 资助金额:
$ 92.44万 - 项目类别:
Role of NLRP3 signals in ischemia/reperfusion-induced organ injury
NLRP3信号在缺血/再灌注引起的器官损伤中的作用
- 批准号:
10494248 - 财政年份:2021
- 资助金额:
$ 92.44万 - 项目类别:
Role of NLRP3 signals in ischemia/reperfusion-induced organ injury
NLRP3信号在缺血/再灌注引起的器官损伤中的作用
- 批准号:
10375997 - 财政年份:2021
- 资助金额:
$ 92.44万 - 项目类别:
AIM2 as a negative regulator of renal ischemia/reperfusion injury
AIM2 作为肾缺血/再灌注损伤的负调节因子
- 批准号:
10043487 - 财政年份:2020
- 资助金额:
$ 92.44万 - 项目类别:
AIM2 as a negative regulator of renal ischemia/reperfusion injury
AIM2 作为肾缺血/再灌注损伤的负调节因子
- 批准号:
10170263 - 财政年份:2020
- 资助金额:
$ 92.44万 - 项目类别:
相似国自然基金
影像组学用于急性病毒性肺炎鉴别诊断的生物学机制探究
- 批准号:82172029
- 批准年份:2021
- 资助金额:55.00 万元
- 项目类别:面上项目
影像组学用于急性病毒性肺炎鉴别诊断的生物学机制探究
- 批准号:
- 批准年份:2021
- 资助金额:55 万元
- 项目类别:面上项目
胆碱能抗炎通路调节巨噬细胞M1/M2极化在CVB3诱导的急性病毒性心肌炎中的作用及机制研究
- 批准号:81870281
- 批准年份:2018
- 资助金额:57.0 万元
- 项目类别:面上项目
急性病毒感染中转录因子Tbet对TFH应答的调控及机制研究
- 批准号:31700774
- 批准年份:2017
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
调控巨噬细胞极化的microRNA分子鉴定及其在CVB3诱导的急性病毒性心肌炎中的作用
- 批准号:81472017
- 批准年份:2014
- 资助金额:80.0 万元
- 项目类别:面上项目
相似海外基金
Mentoring Emerging Researchers at CHLA (MERCH-LA)
指导 CHLA (MERCH-LA) 的新兴研究人员
- 批准号:
10797938 - 财政年份:2023
- 资助金额:
$ 92.44万 - 项目类别:
The role of epigenetic regulator UHRF1 in stability of induced regulatory T-cell function during influenza A virus-induced lung injury
表观遗传调节因子 UHRF1 在甲型流感病毒诱导的肺损伤过程中诱导调节 T 细胞功能稳定性中的作用
- 批准号:
10389878 - 财政年份:2023
- 资助金额:
$ 92.44万 - 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
- 批准号:
10752441 - 财政年份:2023
- 资助金额:
$ 92.44万 - 项目类别:
Development of an Oral Pan-Coronavirus Drug Cocktail
口服泛冠状病毒药物混合物的开发
- 批准号:
10714472 - 财政年份:2023
- 资助金额:
$ 92.44万 - 项目类别:
Host Defense Small Molecule Development for COVID-19 Treatment by Targeting Lysosome
通过靶向溶酶体治疗 COVID-19 的宿主防御小分子开发
- 批准号:
10735492 - 财政年份:2023
- 资助金额:
$ 92.44万 - 项目类别: